1. Ramirez CO. Los cenicientos: Problema clinico. Proceedings of the First Central American Congress of Dermatology. 1957. 1957 Dec 5-8; San Salvador: 122–130.
2. Torrelo A, Zaballos P, Colmenero I, Mediero IG, de Prada I, Zambrano A. Erythema dyschromicum perstans in children: a report of 14 cases. J Eur Acad Dermatol Venereol. 2005. 19:422–426.
Article
3. Osswald SS, Proffer LH, Sartori CR. Erythema dyschromicum perstans: a case report and review. Cutis. 2001. 68:25–28.
4. Urano-Suehisa S, Tagami H, Iwatsuki K. Unilateral ashy dermatosis occurring in a child. Arch Dermatol. 1984. 120:1491–1493.
Article
5. Shirahama S, Yagi H, Takigawa M. A case of ashy dermatosis with unilateral and band-like distribution. Acta Dermatol Kyoto. 1994. 89:15–17.
6. Yokozeki H, Ueno M, Komori K, Nishioka K. Multiple linear erythema dyschromicum perstans (ashy dermatosis) in the lines of Blaschko. Dermatology. 2005. 210:356–357.
Article
7. Schwartz RA. Erythema dyschromicum perstans: the continuing enigma of Cinderella or ashy dermatosis. Int J Dermatol. 2004. 43:230–232.
Article
8. Vasquez-Ochoa LA, Isaza-Guzman DM, Orozco-Mora B, Restrepo-Molina R, Trujillo-Perez J, Tapia FJ. Immunopathologic study of erythema dyschromicum perstans (ashy dermatosis). Int J Dermatol. 2006. 45:937–941.
Article
9. Baranda L, Torres-Alvarez B, Cortes-Franco R, Moncada B, Portales-Perez DP, Gonzalez-Amaro R. Involvement of cell adhesion and activation molecules in the pathogenesis of erythema dyschromicum perstans (ashy dermatitis). The effect of clofazimine therapy. Arch Dermatol. 1997. 133:325–329.
Article
10. Bahadir S, Cobanoglu U, Cimsit G, Yayli S, Alpay K. Erythema dyschromicum perstans: response to dapsone therapy. Int J Dermatol. 2004. 43:220–222.
Article